Regeneron Pharmaceuticals to Open Global Capability Centre in Hyderabad by 2026
US-based Regeneron Pharmaceuticals announced plans to establish a Global Capability Centre (GCC) in Hyderabad, operational by the second half of 2026. The centre will support drug development and digital operations, including data management, AI, clinical trials, and analytics, creating hundreds of jobs. Telangana's IT Minister highlighted Hyderabad's growing life sciences ecosystem, with the GCC expected to strengthen the city's global biotech and capability centre status. Regeneron views this as a strategic investment in expanding its global footprint and leveraging India's talent.